Stocktoria
NANOVIRICIDES, INC. NNVC
NYSE American · XASE · stock · Pharmaceutical Preparations · website · IPO 2004-08-12
NANOVIRICIDES, INC. statistics & valuation
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on assets | -107.3% | -64.7% | -50.8% | -34.5% | -29.2% | -56.2% | -62.6% | -46.2% | -38.2% | -29.3% |
| Return on equity | -125.9% | -72.3% | -57.8% | -35.1% | -29.5% | -61.8% | -79.5% | -48.5% | -50.7% | -46.5% |
| Current ratio | 1.28 | 3.66 | 15.81 | 34.92 | 59.30 | 6.49 | 0.99 | 8.30 | 3.28 | 3.62 |
Source: SEC EDGAR filings · CIK 0001379006 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.